Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | MEDIKON INDIA PRIVATE LIMITED | 1 | ₹57,415.68 |
| 2 | Schedule 2 | SMPL LIFE SCIENCES PRIVATE LIMITED | 1 | ₹1.1 L |
| 3 | Schedule 4 | SMPL LIFE SCIENCES PRIVATE LIMITED | 1 | ₹2.4 L |
| 4 | Schedule 9 | SUMIT PHARMACEUTICALS PRIVATE LIMITED | 1 | ₹5,827.68 |
| 5 | Schedule 10 | SMPL LIFE SCIENCES PRIVATE LIMITED | 1 | ₹42,624 |
Tender Value
₹43.6 L
EMD Value
Exempted
Closing Date
20 Jul 2024, 1:00 pmClosed
IFA 3 DRUGS
6557307
GEM/2024/B/5084780
Two Packet Bid
Albumin bound Paclitaxel 100 mg inj,Atosiban 37 point 5 mg Inj,Human Rabies Immune Globulin 150 IU
45 days
Uttar Pradesh; Lucknow
Item wise evaluation
BOQ
8 documents required · 8 mandatory
1 yrs
₹3
10%
Exempted
20 Jul 2024
29 Jun 2024
20 Jul 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Albumin bound Paclitaxel 100 mg inj | 48 | VIAL | DGLPMS | 45 |
| 2 | Atosiban 37 point 5 mg Inj | 30 | VIAL | DGLPMS | 45 |
| 3 | Human Rabies Immune Globulin 150 IU per ml 2 ml PFS | 12 | PFS | DGLPMS | 45 |
| 4 | Human Rabies Immune Globulin 150 IU per ml 2 ml Vial | 48 | VIAL | DGLPMS | 45 |
| 5 | Indicator Soda lime | 230 | KG | DGLPMS | 45 |
| 6 | Lignocaine HCl solution 2 percentage Inj for IV use 50 ml | 270 | VIAL | DGLPMS | 45 |
| 7 | Lignocaine Hyrochloride 4 percentage topical solution bott of 30 ml | 250 | VIAL | DGLPMS | 45 |
| 8 | Liquor Formaldehyde 40 percentage w per v | 120 | LTR | DGLPMS | 45 |
| 9 | Misoprostol 200mcg Tab | 1,704 | No | DGLPMS | 45 |
| 10 | Neostigmine 0 point 5mg 1ml Inj | 11,100 | AMP | DGLPMS | 45 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6557307.pdf
GEM_BID
ifa_3_bbqr_2024-06-24-13-36-05_939a2d5872a598eaca951b979c94d852.pdf
BOQ
boq_item_sample_file_2024-06-24-13-36-05_a0c680b4bc811d26b628cbd14f226dc3.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .